Published December 2018 | Version v1
Journal article Metadata-only

Prognostic factors of colostomy free survival in patients presenting with locally advanced anal canal carcinoma: A pooled analysis of two prospective trials (KANAL 2 and ACCORD 03)

Creators

  • 1. EA 4360 APEMAC, Université de Lorraine, Nancy (France)
  • 2. Radiation Department, Institut de Cancérologie de Lorraine Alexis-Vautrin, Vandoeuvre-lès-Nancy (France)
  • 3. Radiation Department, Centre Hospitalier Universitaire de Bordeaux – Hôpital Haut-Lévêque, Pessac (France)
  • 4. Department of Radiation Oncology, Institut de Cancérologie de Montpellier – Val d'Aurelle, University of Montpellier (France)
  • 5. Université de Nice, Sophia Antipolis (France)
  • 6. Radiation Department, Centre Antoine Lacassagne, Nice (France)
  • 7. Radiation Department, Centre Oscar Lambret, Lille (France)
  • 8. Unicancer, Paris (France)
  • 9. Biostatistics and Epidemiology Department, Institut de Cancérologie de Lorraine – Alexis-Vautrin, Vandoeuvre-lès-Nancy (France)
  • 10. Inserm CIC 1433 Clinical Epidemiology, and Centre Hospitalier Régional Universitaire de Nancy, Vandoeuvre-lès-Nancy (France)

Description

BackgroundTo carry out a prognosis study of the prospective studies KANAL 2 and ACCORD 03 in order to highlight new prognostic factors of colostomy-free survival in patients with locally advanced anal canal carcinoma.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.radonc.2018.08.008

Additional details

Identifiers

DOI
10.1016/j.radonc.2018.08.008;
PII
S0167814018334467;

Publishing Information

Journal Title
Radiotherapy and Oncology
Journal Volume
129
Journal Issue
3
Journal Page Range
p. 463-470
ISSN
0167-8140
CODEN
RAONDT

INIS

Country of Publication
Ireland
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
51004974
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
CARCINOMAS; CHEMOTHERAPY; FORECASTING; HAZARDS; PATIENTS; RADIOTHERAPY
Descriptors DEC
DISEASES; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; RADIOLOGY; THERAPY

Optional Information

Copyright
Copyright (c) 2017 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.